OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of sodium‐glucose cotransporter‐2 inhibitors and aldosterone antagonists, in addition to renin‐angiotensin system antagonists, on major adverse kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta‐analysis
Shuo Yang, Lu Zhao, Yaochuan Mi, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 11, pp. 2159-2168
Closed Access | Times Cited: 16
Shuo Yang, Lu Zhao, Yaochuan Mi, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 11, pp. 2159-2168
Closed Access | Times Cited: 16
Showing 16 citing articles:
Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: A systematic review and network meta-analysis of randomized controlled trials
Qing Yang, Yanlin Lang, Wenjie Yang, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110592-110592
Closed Access | Times Cited: 36
Qing Yang, Yanlin Lang, Wenjie Yang, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110592-110592
Closed Access | Times Cited: 36
Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease
Javier Morales, Yehuda Handelsman
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 2, pp. 161-170
Open Access | Times Cited: 35
Javier Morales, Yehuda Handelsman
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 2, pp. 161-170
Open Access | Times Cited: 35
Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis
Mainak Banerjee, Indira Maisnam, Rimesh Pal, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3686-3696
Open Access | Times Cited: 23
Mainak Banerjee, Indira Maisnam, Rimesh Pal, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3686-3696
Open Access | Times Cited: 23
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 10
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 10
Mineralocorticoid receptor antagonists and heart failure with preserved ejection fraction: current understanding and future prospects
Xi Chen, Meinv Huang, Yi Chen, et al.
Heart Failure Reviews (2024)
Closed Access | Times Cited: 4
Xi Chen, Meinv Huang, Yi Chen, et al.
Heart Failure Reviews (2024)
Closed Access | Times Cited: 4
Incidence of hyperkalemia RAASi and SGLT-2i treatment in individuals with diabetic kidney disease: a systematic review and network meta-analysis
Yahui Yuan, Chun Chen, Yuping Lin, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Yahui Yuan, Chun Chen, Yuping Lin, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE )
Umanath Adhikari, Hoda Gad, Debajyoti Chatterjee, et al.
Journal of the Peripheral Nervous System (2025) Vol. 30, Iss. 1
Closed Access
Umanath Adhikari, Hoda Gad, Debajyoti Chatterjee, et al.
Journal of the Peripheral Nervous System (2025) Vol. 30, Iss. 1
Closed Access
Chronic Kidney Disease in Diabetes: A Clinical Practice Guideline
Sheldon W. Tobe, Harpreet S. Bajaj, Navdeep Tangri, et al.
Canadian Journal of Diabetes (2025) Vol. 49, Iss. 2, pp. 73-86.e14
Closed Access
Sheldon W. Tobe, Harpreet S. Bajaj, Navdeep Tangri, et al.
Canadian Journal of Diabetes (2025) Vol. 49, Iss. 2, pp. 73-86.e14
Closed Access
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances
Xinping Chen, Xuan Li, Kexin Zhang, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 2, pp. 125-135
Closed Access | Times Cited: 8
Xinping Chen, Xuan Li, Kexin Zhang, et al.
Clinical and Experimental Nephrology (2023) Vol. 28, Iss. 2, pp. 125-135
Closed Access | Times Cited: 8
Controlling nutritional status score is associated with renal progression, cardiovascular events, and all-cause mortality in biopsy-proved diabetic kidney disease
Qingyu Huo, Ting He, Jiachuan Xiong, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 5
Qingyu Huo, Ting He, Jiachuan Xiong, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 5
Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis
Ying Tan, Ziqi Zhang, Peipei Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Ying Tan, Ziqi Zhang, Peipei Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 1
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events
Ashish Upadhyay, Lalarukh Haider
Clinical Diabetes (2024) Vol. 43, Iss. 1, pp. 43-52
Closed Access
Ashish Upadhyay, Lalarukh Haider
Clinical Diabetes (2024) Vol. 43, Iss. 1, pp. 43-52
Closed Access
Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis
Yaru Zhang, Junhui Luo, Bingxin Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Yaru Zhang, Junhui Luo, Bingxin Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Efficacy of Mineralocorticoid Receptor Antagonists on Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: An Umbrella Review
Porntep Amornritvanich, Thunyarat Anothaisintawee, John Attia, et al.
Kidney Medicine (2024) Vol. 7, Iss. 2, pp. 100943-100943
Closed Access
Porntep Amornritvanich, Thunyarat Anothaisintawee, John Attia, et al.
Kidney Medicine (2024) Vol. 7, Iss. 2, pp. 100943-100943
Closed Access
Comparative Efficacy and Safety of Cardio-Renoprotective Pharmacological Interventions in Chronic Kidney Disease: An Umbrella Review of Network Meta-Analyses and a Multicriteria Decision Analysis
Ioannis Bellos, Smaragdi Marinaki, Παγώνα Λάγιου, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 39-39
Open Access
Ioannis Bellos, Smaragdi Marinaki, Παγώνα Λάγιου, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 39-39
Open Access
▼Finerenone for CKD associated with type 2 diabetes
Drug and Therapeutics Bulletin (2023) Vol. 61, Iss. 8, pp. dtb-000017
Closed Access
Drug and Therapeutics Bulletin (2023) Vol. 61, Iss. 8, pp. dtb-000017
Closed Access
Possible amelioration impact of sodium-glucose cotransporter 2 inhibitors on cisplatin-induced renal toxicity; a mini-review on recent findings
Parisa Keshtgar, Leila Mahmoodnia, Samin Karamian
Journal of Renal Injury Prevention (2023) Vol. 12, Iss. 4, pp. e32245-e32245
Open Access
Parisa Keshtgar, Leila Mahmoodnia, Samin Karamian
Journal of Renal Injury Prevention (2023) Vol. 12, Iss. 4, pp. e32245-e32245
Open Access
